Categories: News

Eroxon, FDA Approved for Topical Erectile Dysfunction Treatment, Now Available From Canada Pharmacy

Non-prescription gel goes on topically to counter erectile dysfunction and is an OTC alternative to Viagra.

VICTORIA, BC / ACCESSWIRE / January 23, 2024 / As an OTC alternative to Viagra and Cialis, Eroxon was US FDA-approved on June 13, 2023, and is available from both storefront and online pharmacies, including Canada Pharmacy and others in Canada, which can offer a lower price on Eroxon.

Canada Pharmacy Logo

Eroxon, which comes in single-dose tubes of gel, is also expected to be a comparatively affordable erectile dysfunction treatment. Eroxon received approval in the European Union as a Class 2B medical device in April 2021.

Eroxon is a topical gel with a different mechanism of action compared to these other ED treatment meds. It works with a combination of solvents that evaporate quickly to promote a cooling-to-warming effect, resulting in more nitric oxide relaxing smooth muscle tissue. This enhances blood flow, and it is claimed that Eroxon will take effect within 10 minutes of application.

US residents are increasingly having prescriptions filled in Canada because of the lower costs for prescription medications. This also applies to OTC products, including Eroxon, as it is becoming more available in America.

About the Company

Canada Pharmacy is a Canadian online pharmacy among those recommended for Americans who shop at a pharmacy in Canada to save money on medications. It can source medications in a way that allows for the best prices on prescription drugs from Canada. All orders require a prescription and are dispensed by a licensed pharmacist, in the same way as it would be with any pharmacy in America. Pay less when you order drugs online from Canada.

Contact Canada Pharmacy:

https://www.canadapharmacy.com

info@canadapharmacy.com

Toll Free: 1-800-891-0844

Contact Information

Marketing Team
Marketing Team
marketing@canadapharmacy.com
1-800-891-0844

SOURCE: Canada Pharmacy

View the original press release on newswire.com.

Staff

Recent Posts

Apollo Neuroscience Announces 2025 Year in Review

Community Gains Nearly 144 Million Minutes of Sleep, Wins Best Sleep Wearable of 2025NEW YORK,…

3 hours ago

Paytient Recognized by Modern Healthcare for Transforming Patient Experience

COLUMBIA, Mo., Jan. 30, 2026 /PRNewswire/ -- Paytient, a leader in innovative healthcare affordability and…

3 hours ago

Promino Announces Closing of Private Placement

Burlington, Ontario--(Newsfile Corp. - January 30, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC:…

7 hours ago

NuGen Medical Devices Inc. Announces CFO Transition

Toronto, Ontario--(Newsfile Corp. - January 30, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

9 hours ago

Midmark RTLS launches BLE Sensory Network for smarter, scalable RTLS

New Plug-In BLE Sensors provide a faster, more cost-effective path to facility-wide RTLS coverage with near-room…

9 hours ago

Vrtly, Inc. Unveils End-to-End In-Practice Marketing Platform, Bridging the “Blind Spot” for Brands in Cash-Pay Healthcare

DANVILLE, Calif., Jan. 30, 2026 /PRNewswire/ -- Vrtly, Inc., the premier point-of-care (POC) marketing platform…

9 hours ago